Re: New guidelines to evaluate the response to treatment in solid tumors (ovarian cancer)

被引:227
作者
Rustin, GJS
Quinn, M
Thigpen, T
du Bois, A
Pujade-Lauraine, E
Jakobsen, A
Eisenhauer, E
Sagae, S
Greven, K
Vergote, I
Cervantes, A
Vermorken, J
机构
[1] MRC, Clin Trials Unit, London, England
[2] Gynecol Oncol Grp, Philadelphia, PA 19104 USA
[3] Etude Canc Ovariens, Grp Invest Nat, Paris, France
[4] Nord Soc Gynecol Oncol, Linkoping, Sweden
[5] Natl Canc Inst, Canada Clin Trials Grp, Kingston, ON, Canada
[6] Japanese Gynecol Oncol Grp, Tokyo, Japan
[7] Radiat Therapy Oncol Grp, Philadelphia, PA 19104 USA
[8] European Org Res Treatment Canc, Brussels, Belgium
[9] Spanish Grp Res Ovarian Canc, Barcelona, Spain
[10] Gynaecol Canc Intergrp, Bethesda, MD USA
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2004年 / 96卷 / 06期
关键词
D O I
10.1093/jnci/djh081
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:487 / 488
页数:2
相关论文
共 4 条
[1]  
GUASTALLA JP, 2002, P AN M AM SOC CLIN, V21, pA204
[2]   Phase I clinical trial of weekly combretastatin A4 phosphate: Clinical and pharmacokinetic results [J].
Rustin, GJS ;
Galbraith, SM ;
Anderson, H ;
Stratford, M ;
Folkes, LK ;
Sena, L ;
Gumbrell, L ;
Price, PM .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (15) :2815-2822
[3]  
Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205
[4]   Re: New guidelines to evaluate the response to treatment in solid tumors [ovarian cancer] [J].
Vergote, I ;
Rustin, GJS ;
Eisenhauer, EA ;
Kristensen, GB ;
Pujade-Lauraine, E ;
Parmar, MKB ;
Friedlander, M ;
Jakobsen, A ;
Vermorken, JB .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (18) :1534-1535